Literature DB >> 12837984

Molecular biologic characteristics of seven new cell lines of squamous cell carcinomas of the head and neck and comparison to fresh tumor tissue.

Hans-J Welkoborsky1, Roland Jacob, Seyed H Riazimand, Hubert S Bernauer, Wolf J Mann.   

Abstract

BACKGROUND: Squamous cell carcinoma (SCC) is the most frequent malignant tumor of the upper aerodigestive tract. Cell lines of these tumors facilitate the investigation of various tumor biological parameters. This study was conducted to compare molecular biologic characteristics between cell lines and fresh tumor tissue.
METHODS: In seven SCC-derived cell lines, cytokeratin 5/6 and cytokeratin 19 expression, DNA content, chromosome aberrations and tumorigenicity were assessed in nude rats. Unbalanced numerical and structural chromosomal aberrations were investigated by comparative genomic hybridization (CGH), and results were compared to those obtained in fresh tumor tissues of the same patients.
RESULTS: All cell lines expressed cytokeratins 5/6 and 19, indicating their epidermoid origin. Tumor growth after transplantation into nude rats occurred in five of seven cell lines. Routine histology and immunohistochemical examinations confirmed SCC. Aneuploidy was detected in all cell lines, with a 2c deviation index ranging from 1.9 through 9.5 and a 5c exceeding rate ranging from 2.6 through 36.7%. The most frequent chromosomal aberrations in cell lines were overrepresentations of chromosomal material on chromosomes 15q, 7p (5 cases each), 3q, 5p (4 cases each), and 11q and 17q (3 cases each) and losses of chromosomal material on chromosomes 3p, 18q (3 cases each), and 19p and 7q (2 cases each). Comparing these results to CGH analysis of fresh tumor tissue from the same patients, overrepresentations of chromosomal material on 10q, 20q and 21q, along with loss of chromosomal material on 4q was detected more frequently in primary tumors, whereas overrepresentations on 7p and loss of chromosomal material on 7q were more frequently detected in cell lines. Nevertheless, there was a high degree of similarity of chromosomal alterations in cell lines and corresponding fresh tumor tissue.
CONCLUSION: The data suggest a high degree of genetic similarity between tumor cells of cell lines and the tumors from which they were derived. Therefore, these cell lines can serve as an accurate model to investigate cell biology of SCC in vitro. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12837984     DOI: 10.1159/000071206

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  9 in total

1.  Primary cell lines: false representation or model system? a comparison of four human colorectal tumors and their coordinately established cell lines.

Authors:  Danielle M Pastor; Lisa S Poritz; Thomas L Olson; Christina L Kline; Leonard R Harris; Walter A Koltun; Vernon M Chinchilli; Rosalyn B Irby
Journal:  Int J Clin Exp Med       Date:  2010-02-22

2.  Impact of Secretion-Active Osteoblast-Specific Factor 2 in Promoting Progression and Metastasis of Head and Neck Cancer.

Authors:  Désirée Gül; Andrea Schweitzer; Aya Khamis; Shirley K Knauer; Guo-Bin Ding; Laura Freudelsperger; Ioannis Karampinis; Sebastian Strieth; Jan Hagemann; Roland H Stauber
Journal:  Cancers (Basel)       Date:  2022-05-09       Impact factor: 6.575

3.  Preclinical Head and Neck Squamous Cell Carcinoma Models for Combined Targeted Therapy Approaches.

Authors:  Nina Schoenwaelder; Mareike Krause; Thomas Freitag; Björn Schneider; Sarah Zonnur; Annette Zimpfer; Anne Sophie Becker; Inken Salewski; Daniel Fabian Strüder; Heiko Lemcke; Christina Grosse-Thie; Christian Junghanss; Claudia Maletzki
Journal:  Cancers (Basel)       Date:  2022-05-18       Impact factor: 6.575

4.  Wnt/β-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours.

Authors:  Peter Wend; Liang Fang; Qionghua Zhu; Jörg H Schipper; Christoph Loddenkemper; Frauke Kosel; Volker Brinkmann; Klaus Eckert; Simone Hindersin; Jane D Holland; Stephan Lehr; Michael Kahn; Ulrike Ziebold; Walter Birchmeier
Journal:  EMBO J       Date:  2013-06-04       Impact factor: 11.598

5.  Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.

Authors:  Dimitrios Koutsimpelas; Warut Pongsapich; Ulf Heinrich; Sylvia Mann; Wolf J Mann; Jürgen Brieger
Journal:  Oncol Rep       Date:  2012-01-09       Impact factor: 3.906

6.  A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer.

Authors:  Roland H Stauber; Shirley K Knauer; Negusse Habtemichael; Carolin Bier; Britta Unruhe; Simona Weisheit; Stephanie Spange; Frank Nonnenmacher; Verena Fetz; Torsten Ginter; Sigrid Reichardt; Claus Liebmann; Günter Schneider; Oliver H Krämer
Journal:  Oncotarget       Date:  2012-01

7.  Detection of occult carcinomatous diffusion in lymph nodes from head and neck squamous cell carcinoma using real-time RT-PCR detection of cytokeratin 19 mRNA.

Authors:  L Tao; M Lefèvre; S Ricci; P Saintigny; P Callard; S Périé; R Lacave; J-F Bernaudin; J Lacau St Guily
Journal:  Br J Cancer       Date:  2006-04-24       Impact factor: 7.640

8.  Fluorescein- and EGFR-Antibody Conjugated Silica Nanoparticles for Enhancement of Real-time Tumor Border Definition Using Confocal Laser Endomicroscopy in Squamous Cell Carcinoma of the Head and Neck.

Authors:  Anna Watermann; Rita Gieringer; Anna-Maria Bauer; Sven Kurch; Ralf Kiesslich; Wolfgang Tremel; Jan Gosepath; Juergen Brieger
Journal:  Nanomaterials (Basel)       Date:  2019-09-26       Impact factor: 5.076

9.  Phosphoproteome Profiling Reveals Multifunctional Protein NPM1 as part of the Irradiation Response of Tumor Cells.

Authors:  Nadine Wiesmann; Rita Gieringer; Franz Grus; Juergen Brieger
Journal:  Transl Oncol       Date:  2018-11-16       Impact factor: 4.243

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.